143 related articles for article (PubMed ID: 8996977)
1. Cellular effect of thermal neutron capture treatment using 10B1-para-boronophenylalanine: lethal effect on melanoma cells with different degrees of X-ray sensitivity.
Utsumi H; Tano K; Mizuma N; Kobayashi T; Ichihashi M
J Radiat Res; 1996 Sep; 37(3):193-8. PubMed ID: 8996977
[TBL] [Abstract][Full Text] [Related]
2. Specific killing effect of 10B1-para-boronophenylalanine in thermal neutron capture therapy of malignant melanoma: in vitro radiobiological evaluation.
Ichihashi M; Nakanishi T; Mishima Y
J Invest Dermatol; 1982 Mar; 78(3):215-8. PubMed ID: 7057053
[TBL] [Abstract][Full Text] [Related]
3. Selective boron accumulation in human ocular melanoma vs surrounding eye components after 10B1-p-boronophenylalanine administration. Prerequisite for clinical trial of neutron-capture therapy.
Wadabayashi N; Honda C; Mishima Y; Ichihashi M
Melanoma Res; 1994 Jun; 4(3):185-90. PubMed ID: 7919964
[TBL] [Abstract][Full Text] [Related]
4. Relative biological effectiveness (RBE) of thermal neutron capture therapy of cultured B-16 melanoma cells preincubated with 10B-paraboronophenylalanine.
Ichihashi M; Sasase A; Hiramoto T; Funasaka Y; Hatta S; Mishima Y; Kobayashi T; Fukuda H; Yoshino K
Pigment Cell Res; 1989; 2(4):325-9. PubMed ID: 2798325
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of the high-LET radiations from the boron neutron capture [10B(n,α) 7Li] reaction determined for induction of chromosome aberrations and apoptosis in lymphocytes of human blood samples.
Schmid TE; Canella L; Kudejova P; Wagner FM; Röhrmoser A; Schmid E
Radiat Environ Biophys; 2015 Mar; 54(1):91-102. PubMed ID: 25428113
[TBL] [Abstract][Full Text] [Related]
6. Neutron capture therapy of intracerebral melanoma: enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine.
Barth RF; Yang W; Bartus RT; Rotaru JH; Ferketich AK; Moeschberger ML; Nawrocky MM; Coderre JA; Rofstad EK
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):858-68. PubMed ID: 11849812
[TBL] [Abstract][Full Text] [Related]
7. [Neutron capture therapy for cancer].
Fukuda H; Ichihashi M; Mishima Y
Gan To Kagaku Ryoho; 1994 Feb; 21(3):374-8. PubMed ID: 8109994
[TBL] [Abstract][Full Text] [Related]
8. Neutron irradiation of human melanoma cells.
Brown K; Mountford MH; Allen BJ; Mishima Y; Ichihashi M; Parsons P
Pigment Cell Res; 1989; 2(4):319-24. PubMed ID: 2798324
[TBL] [Abstract][Full Text] [Related]
9. Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent.
Matalka KZ; Bailey MQ; Barth RF; Staubus AE; Soloway AH; Moeschberger ML; Coderre JA; Rofstad EK
Cancer Res; 1993 Jul; 53(14):3308-13. PubMed ID: 8324742
[TBL] [Abstract][Full Text] [Related]
10. Human melanoma treated by boron neutron capture therapy: comparison of the clinical response with the predicted response.
Hiratsuka J; Fukuda H; Kobayashi T; Kanda K; Honda C; Ichihashi M; Mishima Y
Radiat Med; 1996; 14(5):257-63. PubMed ID: 8988505
[TBL] [Abstract][Full Text] [Related]
11. Boron neutron capture therapy of primary and metastatic brain tumors.
Barth RF; Soloway AH
Mol Chem Neuropathol; 1994; 21(2-3):139-54. PubMed ID: 8086033
[TBL] [Abstract][Full Text] [Related]
12. Boron neutron capture therapy of anterior chamber melanoma with p-boronophenylalanine.
Packer S; Coderre J; Saraf S; Fairchild R; Hansrote J; Perry H
Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):395-403. PubMed ID: 1740371
[TBL] [Abstract][Full Text] [Related]
13. In situ detection of cutaneous melanoma by prompt gamma-ray spectrometry using melanoma-seeking 10B-dopa analogue.
Honda C; Mishima Y; Ichihashi M; Hatta S
J Dermatol Sci; 1990 Jan; 1(1):23-31. PubMed ID: 2078538
[TBL] [Abstract][Full Text] [Related]
14. [Neutron capturing irradiation: principle, current results and perspectives].
Pignol JP; Chauvel P
Bull Cancer Radiother; 1995; 82(3):283-97. PubMed ID: 8554878
[TBL] [Abstract][Full Text] [Related]
15. Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy.
Coderre JA; Glass JD; Fairchild RG; Roy U; Cohen S; Fand I
Cancer Res; 1987 Dec; 47(23):6377-83. PubMed ID: 3677082
[TBL] [Abstract][Full Text] [Related]
16. Boron neutron capture therapy of a murine melanoma with p-boronophenylalanine: dose-response analysis using a morbidity index.
Coderre JA; Slatkin DN; Micca PL; Ciallella JR
Radiat Res; 1991 Nov; 128(2):177-85. PubMed ID: 1947013
[TBL] [Abstract][Full Text] [Related]
17. Cellular binding of carboranylalanine and some effects of boron neutron capture. Analysis of cultured melanoma B16 cells.
Pettersson OA; Olsson P; Lindström P; Sjöberg S; Larsson BS; Carlsson J
Acta Oncol; 1994; 33(6):685-91. PubMed ID: 7946449
[TBL] [Abstract][Full Text] [Related]
18. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
19. Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA-BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch.
Aromando RF; Trivillin VA; Heber EM; Pozzi E; Schwint AE; Itoiz ME
Oral Oncol; 2010 May; 46(5):355-9. PubMed ID: 20308008
[TBL] [Abstract][Full Text] [Related]
20. Selective uptake of p-borophenylalanine by undifferentiated thyroid carcinoma for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Kreimann E; Farías S; Garavaglia R; Agote M; Cabrini RL; Dadino JL; Juvenal GJ; Pisarev MA
Thyroid; 2002 Jan; 12(1):7-12. PubMed ID: 11838734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
